Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
Post-exertional malaise is not deconditioning. The standard advice — exercise more, push through it — has caused real harm. You deserve care that knows the difference.
What we mean when we say ME/CFS.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) is a complex multi-system illness defined by post-exertional malaise (PEM) — a worsening of symptoms after physical, cognitive, or emotional exertion that is disproportionate, delayed, and prolonged. Additional core features include unrefreshing sleep, cognitive dysfunction, and orthostatic intolerance.
ME/CFS is severely under-recognized and severely under-funded. The CDC estimates 17–24 million worldwide; with corrected analyses, the true figure may approach 70 million. Over 60% of cases are undiagnosed.
The single most important clinical lesson of ME/CFS is that graded exercise therapy is contraindicated for most patients. Pacing, energy envelope management, and component-specific evaluation (autonomic, mast cell, sleep architecture, infectious triggers) are the foundations of evidence-aligned care.
CDC estimates 17–24 million worldwide. Corrected analyses suggest up to 70 million. Over 60% of cases are estimated to be undiagnosed.
Why ME/CFS gets missed.
ME/CFS is the condition most consistently failed by standard care. The post-exertional malaise that defines it is rarely asked about specifically, graded exercise — which is contraindicated — is still routinely prescribed, and the systemic context that frequently accompanies it goes unevaluated. The result is decades of patient harm that the recent literature is only beginning to correct.
- 01Post-exertional malaise is the core diagnostic feature, but it is rarely asked about specifically. Many ME/CFS patients are diagnosed with fatigue, depression, or deconditioning when PEM is the actual driver.
- 02Graded exercise therapy is contraindicated in ME/CFS — the PACE trial that promoted it has been substantially discredited, and post-exertional malaise means structured exercise can cause meaningful harm. Many patients are still prescribed it.
- 03Autonomic dysfunction is present in the majority of ME/CFS patients, and POTS is a common comorbid diagnosis. Yet the 10-minute stand test that would identify POTS is rarely performed in ME/CFS workups.
- 04Mast cell activation, small fiber neuropathy, sleep architecture disorders, and post-infectious immune findings are all frequently present and frequently unevaluated. The disease is treated as 'fatigue' rather than as the multi-system condition the literature establishes it to be.
The Ternary Health approach to ME/CFS.
Characterize the post-exertional malaise pattern specifically — onset delay, duration, severity, triggers — because PEM presence determines everything downstream, especially the question of structured exercise versus pacing.
Evaluate the autonomic component — POTS criteria, autonomic reflex screen, orthostatic intolerance pattern — that frequently drives symptom intensity and that responds to specific interventions.
Audit for mast cell activation, small fiber neuropathy, sleep architecture, and post-infectious immune findings that frequently coexist with ME/CFS and that change management when identified.
Build the pacing and energy-envelope strategy explicitly. Activity management is the foundation of ME/CFS care, and most patients have never been given a structured pacing protocol calibrated to their PEM threshold.
The Ternary Signal Library for ME/CFS.
Our Signal Library for ME/CFS codifies the specific patterns that matter — post-exertional malaise characterization, autonomic and orthostatic findings, sleep and cognitive architecture, and the mast cell and infectious-trigger patterns that frequently coexist. Your case is mapped against these signals; each present signal is identified and prioritized for your presentation.
- —PEM presence per IOM 2015 criteria
- —Onset delay after exertion — typically 12 to 48 hours
- —Duration and severity pattern
- —Cognitive, physical, and emotional triggers
- —DePaul Symptom Questionnaire or equivalent structured assessment
- —10-minute stand or tilt-table for POTS criteria
- —Autonomic reflex screen — sudomotor, cardiovagal, adrenergic
- —Heart rate variability patterns
- —Orthostatic hypotension differential
- —Cerebral blood flow findings where measured
- —Polysomnography findings — unrefreshing sleep pattern
- —Sleep apnea screening — frequently coexistent and missed
- —Cognitive dysfunction characterization — working memory, processing speed
- —Neuropsychological testing where performed
- —Sleep timing, duration, and refreshment quality
- —MCAS evaluation — frequently coexistent with ME/CFS
- —Triggering infection history — viral, bacterial, tick-borne
- —Reactivated EBV, HHV-6, CMV screening
- —Long COVID overlap in post-2020 onset cases
- —Small fiber neuropathy and autoimmune marker screening
How a ME/CFS case moves through our workflow.
Our nine-stage workflow is the same for every engagement. What changes per condition is the content at each stage — the records we pull, the signals we apply, the specialists we map, the pathways we evaluate. Below, how your case specifically would move through each stage.
What you receive.
- —A written case synthesis characterizing PEM pattern and the specific drivers in your ME/CFS
- —Integration of autonomic, sleep, mast cell, and infectious-trigger findings into a single view
- —Pacing and energy-envelope prescription calibrated to your PEM threshold
- —Activity-prescription appropriateness determination explicitly addressing graded exercise question
- —Comorbid management plan across autonomic, mast cell, sleep, and small fiber domains
- —Specialist identification for ME/CFS-experienced clinicians and indicated comorbid workups
- —A written action plan and follow-up support as you implement it
What a Precision Deep Dive provides for ME/CFS.
A Ternary Health Precision Deep Dive for ME/CFS characterizes the PEM pattern and severity, evaluates autonomic, mast cell, sleep, and infectious-trigger components, audits pharmacologic and non-pharmacologic management evidence including pacing protocols, and synthesizes the evolving clinical trial landscape.
See the published sample reports · read the Ternary Method
What we look for alongside ME/CFS.
Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome frequently present with one or more of the following. Ternary reports evaluate the full picture rather than the condition in isolation.
What prospective Myalgic Encephalomyelitis / Chronic Fatigue Syndrome clients ask most.
Three ways to engage Ternary on ME/CFS.
From a free starting point to a full personalized action plan — three tiers, one methodology, all tailored to ME/CFS.
Free Brief
A 3–5 page personalized starting point on your condition. Most relevant labs, specialist categories, first decisions worth pursuing. No charge.
Generated instantly, no charge.
Get a free Brief→Launchpad
A research-based preparedness guide. Current literature, realistic prognosis, test and treatment categories worth exploring, and a checklist of what you might consider to better manage and understand your condition.
Delivered in 3–5 business days
Start a Launchpad→Precision Deep Dive
A vigorously researched and highly personalized action plan: the specialists and centers of excellence worth considering, evidence-graded options, and a prioritized set of questions to raise — all curated for your specific condition and lifestyle, for you and your physicians to weigh together. The plan includes 30 days of follow-up support and tailored insights into how best to navigate your situation now and in the future.
September 2026 cohort
Apply for a Deep Dive→See exactly what you receive.
A composite sample illustrating the structure and depth of every Ternary Health Precision Deep Dive. Same universal 17-section format used for ME/CFS — drawn from four research-validated patient profiles across four conditions.
Every Ternary engagement produces a report with the same architecture: client profile, applied methodology, signal analysis, lab and genetic findings, imaging synthesis, disease model, intervention prioritization, specialist pathway, staged medical therapy, 90-day roadmap, and monitoring cadence. The composite shows you exactly how that architecture renders.
Ready for clarity on your ME/CFS?
Applications for the September 2026 cohort are open now and reviewed in the order received. Not ready? A free Ternary Brief on ME/CFS is generated instantly, no charge.